ARCHIVES

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

Court Forces CPSC To Reopen Carcinogen Policy

January 19, 1979

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

NTP Release Third Report On Carcinogens

January 13, 1984

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not

July 3, 1981